Are Clinical Trial Sites Facing Extinction? Digital Twins Could Change EVERYTHING for Pharma! 🤯

The notion that major pharmaceutical players, even revered ones like Eli Lilly, could soon receive regulatory clearance to sidestep traditional Contract Research Organizations (CROs) and physical testing locations for certain studies is a seismic thought. This perspective delves into a scenario where empowering drug sponsors with sophisticated digital twin simulation technology renders the need for on-site patient recruitment obsolete. Consider the implications when the familiar process of negotiating contracts with a specific site, like that much-loved location in Yuma, becomes a choice rather than a necessity. A truly disruptive look at the cutting edge of medical research.
#DigitalTwin #ClinicalTrials #PharmaInnovation #DrugDevelopment #FutureofMedicine #MedTech #RegulatoryScience #CRO #Simulation

Видео Are Clinical Trial Sites Facing Extinction? Digital Twins Could Change EVERYTHING for Pharma! 🤯 канала Dan Sfera